A genetic approach will be used to analyze the specific chemical contacts made between the E. coli Trp repressor and its 20 base pair operator, and the bacteriophage Gamma repressor and its 17 base pair operator. Oligonucleotide-directed localized random mutagenesis will be used to alter each of the condons in the two repressor genes representing amino acid residues thought to be critical for DNA binding. In this way, pools of mutant plasmid producers of each repressor will be constructed. Each pool will include plasmids that produce repressors differing at a single amino acid residue position and that carry each of the 20 possible amino acids at this position. From each pool, we will select mutant repressors that have novel DNA binding properties. altered specificity and hyperrepressor mutants will be selected by virtue of their ability to repress operators that are insensitive to the binding of wild-type repressor, and distinguished by their ability or inability to bind the wild-type operator. In addition, we will select or screen dominant negative mutations in each repressor gene that specifically interfere with binding to the wild-type operator. The ability of each mutant repressor to bind a complete set of mutant operators carrying each possible pair of symmetric base pair substitution will be tested. Mutations that confer informative DNA binding phenotypes will be defined precisely by DNA sequence analysis. In collaboration with other laboratories, we will determine the DNA binding properties of the informative mutant repressors in vitro. The long-term goal of this research is an understanding of the chemical basis of gene expression-- how proteins recognize specific nucleic acid sequences. The understanding of gene regulation is central to the understanding of normal development in higher organisms and of the diseases that result when these regulatory processes go awry.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM034150-06
Application #
3284688
Study Section
Microbial Physiology and Genetics Subcommittee 2 (MBC)
Project Start
1984-01-01
Project End
1989-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
6
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Southern California
Department
Type
Schools of Arts and Sciences
DUNS #
041544081
City
Los Angeles
State
CA
Country
United States
Zip Code
90033
Grinberg, O Y; James, P E; Swartz, H M (1998) Are there significant gradients of pO2 in cells? Adv Exp Med Biol 454:415-23
Chapman, D; Hochstrasser, R; Millar, D et al. (1995) Engineering proteins without primary sequence tryptophan residues: mutant trp repressors with aliphatic substitutions for tryptophan side chains. Gene 163:1-11
Pfau, J; Arvidson, D N; Youderian, P et al. (1994) A site-specific endonuclease derived from a mutant Trp repressor with altered DNA-binding specificity. Biochemistry 33:11391-403
Arvidson, D N; Arvidson, C G; Lawson, C L et al. (1994) The tryptophan repressor sequence is highly conserved among the Enterobacteriaceae. Nucleic Acids Res 22:1821-9
Burz, D S; Beckett, D; Benson, N et al. (1994) Self-assembly of bacteriophage lambda cI repressor: effects of single-site mutations on the monomer-dimer equilibrium. Biochemistry 33:8399-405
Benson, N; Adams, C; Youderian, P (1994) Genetic selection for mutations that impair the co-operative binding of lambda repressor. Mol Microbiol 11:567-79
Arvidson, D N; Pfau, J; Hatt, J K et al. (1993) Tryptophan super-repressors with alanine 77 changes. J Biol Chem 268:4362-9
Shapiro, M; Arvidson, D N; Pfau, J et al. (1993) The challenge-phage assay reveals differences in the binding equilibria of mutant Escherichia coli Trp super-repressors in vivo. Nucleic Acids Res 21:5661-6
Benson, N; Adams, C; Youderian, P (1992) Mutant lambda repressors with increased operator affinities reveal new, specific protein-DNA contacts. Genetics 130:17-26
Arvidson, D N; Youderian, P; Schneider, T D et al. (1991) Automated kinetic assay of beta-galactosidase activity. Biotechniques 11:733-4, 736, 738

Showing the most recent 10 out of 18 publications